120 related articles for article (PubMed ID: 28259519)
1. Antigenic fingerprinting of diphtheria toxoid adsorbed to aluminium phosphate.
Westdijk J; Metz B; Spruit N; Tilstra W; van der Gun J; Hendriksen C; Kersten G
Biologicals; 2017 May; 47():69-75. PubMed ID: 28259519
[TBL] [Abstract][Full Text] [Related]
2. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
[TBL] [Abstract][Full Text] [Related]
3. Effect of different concentrations of diphtheria toxoid & aluminum phosphate on potency of diphtheria component in DPT vaccines.
Gupta P; Saxena SN; Kumar A; Gupta P
Indian J Med Res; 1990 May; 91():171-3. PubMed ID: 2118880
[TBL] [Abstract][Full Text] [Related]
4. Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant.
Vrieling H; Espitia Ballestas M; Hamzink M; Willems GJ; Soema P; Jiskoot W; Kersten G; Metz B
Colloids Surf B Biointerfaces; 2019 Sep; 181():648-656. PubMed ID: 31212137
[TBL] [Abstract][Full Text] [Related]
5. In vitro induction of a diphtheria toxoid specific antibody response in human peripheral blood lymphocytes cultivated in the presence of diphtheria toxoid.
Loggen HG; Kreeftenberg JG
J Biol Stand; 1989 Oct; 17(4):311-9. PubMed ID: 2613706
[TBL] [Abstract][Full Text] [Related]
6. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
Gupta RK; Griffin P; Rivera R; Siber GR
Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
[TBL] [Abstract][Full Text] [Related]
7. The role of the adsorption process for production and control combined adsorbed vaccines.
Matheis W; Zott A; Schwanig M
Vaccine; 2001 Oct; 20(1-2):67-73. PubMed ID: 11567747
[TBL] [Abstract][Full Text] [Related]
8. Results obtained with diphtheria phosphate toxoid.
TASMAN A; LEBRET JD
Bull World Health Organ; 1954; 10(6):951-82. PubMed ID: 13199659
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials of diphtheria toxoid aluminium-phosphate-precipitated; to determine optional aluminium-phosphate content.
BOUSFIELD G
Lancet; 1947 Mar; 1(6443-6445):286-8. PubMed ID: 20287148
[No Abstract] [Full Text] [Related]
10. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
Aggerbeck H; Heron I
Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
[TBL] [Abstract][Full Text] [Related]
11. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
Gupta RK; Siber GR
Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
[TBL] [Abstract][Full Text] [Related]
12. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus.
Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC
Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
15. Preparation and use of calcium phosphate adsorbed vaccines.
Relyveld EH
Dev Biol Stand; 1986; 65():131-6. PubMed ID: 3549396
[TBL] [Abstract][Full Text] [Related]
16. NEW and nonofficial remedies: diphtheria toxoid, aluminum hydroxide adsorbed.
J Am Med Assoc; 1950 May; 143(3):241. PubMed ID: 15415257
[No Abstract] [Full Text] [Related]
17. Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability.
Johansen P; Merkle HP; Gander B
Biochim Biophys Acta; 1998 Oct; 1425(2):425-36. PubMed ID: 9795259
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
19. [Immunizing strength and tolerance by the human organism of vaccines adsorbed on calcium phosphate].
Martin R; Relyveld EH; Raynaud M; Damas JP; Henocq E
Presse Med (1893); 1969 Feb; 77(10):341-4. PubMed ID: 5796019
[No Abstract] [Full Text] [Related]
20. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
